My research focuses on the reproductive health of people whose fertility is shaped by serious illness — particularly the long-term reproductive outcomes of people with cancer diagnoses and survivors — alongside work in ovarian reserve and reproductive aging, the outcomes of assisted reproduction, uterine fibroids, and the ethics of reproductive medicine. A selection of my published work is grouped by theme below. (Earlier publications appear under my prior surname, Dillon.)

Fertility Preservation, Oncofertility & Ovarian Reserve

• Yano Maher JC, Kumnick A, Sinaii N, Su HI, Cameron KE, George SA, Gracia C, Meacham LR, Gomez-Lobo V. A mega-analysis of anti-Müllerian hormone levels in female childhood cancer survivors based on treatment risk, time since treatment, and pubertal status. J Adolesc Young Adult Oncol. 2025.

• Ellington TD, Wardell AC, Deal AM, Mersereau J, Cameron K, Spandorfer S, Murugappan G, Baker VL, Anders C, Mitra S, Anderson C, Cai J, Luke B, Nichols HB. In vitro fertilization with cryopreserved oocytes or embryos after cancer: the role of gestational carriers. Cancer. 2025.

• Hopeman MM, Cameron KE, Prewitt M, Barnhart K, Ginsberg JP, Sammel MD, Gracia CR. A predictive model for chemotherapy-related diminished ovarian reserve in reproductive-age women. Fertil Steril. 2021.

• Chemerinski A, Cameron KE, Sammel MD, Ginsberg JP, Carlson CC, Gracia CR. Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors. J Cancer Surviv. 2020.

• Cameron KE, Sammel MD, Prewitt M, Gracia CR. Differential rates of change in measures of ovarian reserve in young cancer survivors across the reproductive lifespan. J Clin Endocrinol Metab. 2019.

• Cameron KE, Kole MB, Sammel MD, Ginsberg JP, Gosiengfiao Y, Mersereau JE, Su HI, Gracia CR. Acute menopausal symptoms in young cancer survivors immediately following chemotherapy. Oncology. 2018.

• Milman LW, Senapati S, Sammel MD, Cameron KE, Gracia C. Assessing reproductive choices of women and the likelihood of oocyte cryopreservation in the era of elective oocyte freezing. Fertil Steril. 2017.

• Johnson LN, Sammel MD, Dillon KE, Lechtenberg L, Schanne A, Gracia CR. Anti-Müllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception. Fertil Steril. 2014.

• Kondapalli LA, Dillon KE, Sammel MD, Ray A, Prewitt M, Ginsberg JP, Gracia CR. Quality of life in female cancer survivors: is it related to ovarian reserve? Qual Life Res. 2014.

• Dillon KE, Sammel MD, Ginsberg JP, Lechtenberg L, Prewitt M, Gracia CR. Pregnancy after cancer: results from a prospective cohort study of cancer survivors. Pediatr Blood Cancer. 2013.

• Dillon KE, Sammel MD, Prewitt M, Ginsberg JP, Walker D, Mersereau JE, Gosiengfiao Y, Gracia CR. Pretreatment anti-Müllerian hormone levels determine rate of posttherapy ovarian reserve recovery. Fertil Steril. 2013.

• Johnson L, Dillon KE, Sammel M, Mainigi M, Gracia CR. Response to ovarian stimulation in patients facing gonadotoxic therapy. Reprod Biomed Online. 2013.

• Pecker LH, Cameron K. Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women. Expert Rev Hematol. 2024. (Review)

• Dillon KE, Gracia CR. Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol. 2012. (Review)

• Dillon KE, Gracia CR. What is normal ovarian reserve? Semin Reprod Med. 2013. (Review)

IVF & Assisted Reproduction Outcomes

• Henshaw CA, Kirschen G, Chen LX, Cameron KE, Vaught A, Christianson MS. Severe ovarian hyperstimulation syndrome requiring recurrent large-volume paracenteses until 21 weeks' gestation: a case report. F S Rep. 2022.

• Eisenberg M, Luke B, Cameron KE, Shaw G, Pacey A, Sutcliffe A, Williams C, Gardiner J, Anderson R, Baker V. Defining critical factors in multi-country studies of assisted reproductive technologies (ART): data from the US and UK health systems. J Assist Reprod Genet. 2020.

• Cameron K, Luke B, Murugappan G, Baker V. Assisted reproductive technology and cardiovascular risk in women. Curr Cardiovasc Risk Rep. 2024. (Review)

Uterine Fibroids & Reproductive Health

• Cameron KE, Borahay M, Hong X, Baker V, Wang X. Uterine fibroids and risk of hypertensive disorders of pregnancy — results from a high-risk cohort. 2024.

• Nasab S, Gough E, Nylander E, Baker V, Wang X, Cameron KE. Uterine fibroids and hypertensive disorders of pregnancy: a systematic review and meta-analysis. 2024.

Early Pregnancy & Pregnancy of Unknown Location

• Cameron KE, Senapati S, Sammel MD, Chung K, Takacs P, Molinaro T, Barnhart KT. Following declining human chorionic gonadotropin values in pregnancies of unknown location: when is it safe to stop? Fertil Steril. 2016.

• Dillon KE, Sioulas V, Sammel MD, Chung K, Takacs P, Barnhart KB. How and when human chorionic gonadotropin (hCG) curves in women with an ectopic pregnancy mimic other outcomes, and differences by race and ethnicity. Fertil Steril. 2012.

Reproductive Ethics

• Cameron KE, Gracia CR. Social egg freezing and fertility preservation. In: King LP, Band IC, eds. Case Studies in the Ethics of Assisted Reproduction. Springer. (Book chapter)

• Cameron KE, Butts S. Posthumous sperm/gamete use. In: King LP, Band IC, eds. Case Studies in the Ethics of Assisted Reproduction. Springer. (Book chapter)

• Dillon KE, Fiester A. Sperm and oocyte cryopreservation: comprehensive consent and the protection of patient autonomy. Hum Reprod. 2012.